A Randomized Phase 2 Study Comparing Acalabrutinib with or without Obinutuzumab in the Treatment of Early Stage High Risk Patients with Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Sameer A. Parikh, Eli Muchtar, Betsy Laplant, Wei Ding, Sikander Ailawadhi, Amber Koehler, Timothy G. Call, Saad S. Kenderian, Jose F. Leis, Amie Fonder, Min Shi, Asher A. Chanan-Khan, Adam Pettinger, Thomas E. Witzig, Carrie A. Thompson, Jose C Villasboas, Jessica M Sholes, Curtis A. Hanson, Esteban Braggio, Kay L. Medina, Susan L. Slager, Neil E. Kay
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2983826296